Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-26

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved the original ANDA for methylphenidate hydrochloride (LA) from Dr. Reddy's Laboratories Inc., a generic long-acting formulation for treating ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (LA) (Methylphenidate hydrochloride)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE)